Details for Patent: 9,199,973
✉ Email this page to a colleague
Title: | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
Abstract: | A pharmaceutical formulation comprising the compound of formula ##STR00001## |
Inventor(s): | Carter; Malcolm Clive (Stevenage, GB), Cockerill; George Stuart (Stevenage, GB), Lackey; Karen Elizabeth (Durham, NC) |
Assignee: | Novartis AG (Basel, CH) |
Filing Date: | Nov 10, 2014 |
Application Number: | 14/536,896 |
Claims: | 1. A method of treating breast cancer by administering a pharmaceutical formulation presented in unit dose form comprising the compound of formula ##STR00055## as an active ingredient, wherein said active ingredient is present within said unit dose form in an amount from 0.5 mg to 1 g. 2. The method of claim 1, wherein the pharmaceutical formulation is administered as a single dose per day. 3. The method of claim 1, wherein the pharmaceutical formulation is administered as a number of sub-doses per day. 4. The method of claim 1, wherein said unit dose is a tablet. |